RELATED CONTENT
NEWS
- Merck Serono ditches cladribine, leaving MS franchise exposed
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma
- ARISTOTLE: changing thinking about BMS/Pfizer's Eliquis in anticoagulation?
- AstraZeneca heartened by US FDA nod to antiplatelet medicine Brilinta

